Granted Patent
B2
US 11,325,906 · App. 16/931,792 · Granted May 10, 2022
Chemical compounds
Inventors:
Jeffrey Wallace Johannes (Wilmington, DE); Sudhir Mahadeo Hande (Wilmington, DE); Sebastien Louis Degorce (Wilmington, DE); Martin John Packer (Cambridge, GB)
Assignee:
ASTRAZENECA AB
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to azaquinolone compounds of Formula (I), and their use in medicine.
Claims (2)
1. A compound which is 5-[4-[(7-ethyl-6-oxo-5H-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl]-N-methyl-pyridine-2-carboxamide, or a pharmaceutically acceptable salt thereof.
2. A compound which is 5-[4-[(7-ethyl-6-oxo-5H-1,5-naphthyridin-3-yl)methyl]piperazin- 1 -yl]-N-methyl-pyridine-2-carboxamide.
Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 22, 2020
From: ASTRAZENECA PHARMACEUTICALS LP
To: ASTRAZENECA UK LIMITED
Reel/Frame 054723/0315 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 22, 2020
From: DEGORCE, SEBASTIEN LOUIS; JOHANNES, JEFFREY WALLACE; HANDE, SUDHIR MAHADEO
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 054827/0126 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 22, 2020
From: ASTRAZENECA UK LIMITED
To: ASTRAZENECA AB
Reel/Frame 054827/0486 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 22, 2020
From: PACKER, MARTIN JOHN
To: ASTRAZENECA UK LIMITED
Reel/Frame 055663/0970 →
Continuity (2)
Provisional Application
62876065
· Jul 19, 2019
Cited By (2)